Status:
COMPLETED
Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD)
Lead Sponsor:
Sheba Medical Center
Conditions:
Schizophrenia
Obsessive Compulsive Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Comparing schizophrenic patients with comorbid OCD and schizophrenic patients without OCD in response to Ziprasidone and in cognitive functioning as compared with OCD patients
Eligibility Criteria
Inclusion
- Diagnosis of Schizophrenia and OCD for at least 6 months
- Minimum score of 14 on YBOCS
- Minimum score of 60 on PANSS
- Diagnosis of Schizophrenia without OC symptoms
Exclusion
- Patients who are already being treated with ziprasidone
- Diagnosis of schizophreniform disorder
- Organic brain syndrome, mental retardation and pervasive developmental disorder
- Patients having any significantly cardiovascular illness or electrolyte imbalance
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00229385
Start Date
January 1 2006
End Date
April 1 2010
Last Update
December 31 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chaim Sheba Medical Center
Ramat Gan, Israel, 52621